EUVIMEDEUVIMED entdecken
Crossref

RET in the Genomic Era: Moderate Risk Has Become the Majority

Elizabeth E. Cottrill

Clinical Thyroidology® · 01.03.2026 · 38 (3) · 80-83

DOI: 10.1177/23299711261436481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 22.04.2026. Verfasst von Elizabeth E. Cottrill. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cottrill, E. E. (2026). RET in the Genomic Era: Moderate Risk Has Become the Majority. Clinical Thyroidology®, 38(3), 80-83. https://doi.org/10.1177/23299711261436481

Vancouver

Cottrill EE. RET in the Genomic Era: Moderate Risk Has Become the Majority. Clinical Thyroidology®. 2026;38(3):80-83. doi:10.1177/23299711261436481

BibTeX
@article{Cottrill2026,
  author = {Cottrill, Elizabeth E.},
  title = {RET in the Genomic Era: Moderate Risk Has Become the Majority},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {3},
  pages = {80--83},
  doi = {10.1177/23299711261436481}
}
Kostenlos starten →